2-es típusú cukorbetegség: vizsgálatok itt: Spanyolország
46 of 57 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 19.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in SpanyolországA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- A Coruña, Alzira, Barcelona, Ferrol, Granada, Málaga, Seville
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - 3. fázisNot yet taking people in SpanyolországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- A Coruña, Alzira, Castilleja De La Cuesta, Ferrol, Granada, Lugo, Madrid, Majadahonda, Palma, Pozuelo de Alarcón, Santander, Sevilla, Valencia
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Badalona, Barcelona, Córdoba, Galdakao, Granada, Huelva, Jaén, Las Palmas De Gran Canaria, Madrid, Sabadell, Santander, Sevilla, Toledo, Valencia, Valladolid, Vigo, Villamartín
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 2. fázisFut, nem toborozA Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Where
- A Coruña, Barcelona, Castilleja De La Cuesta, Ferrol, Madrid, Málaga, Santander, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07112872 · EU 2024-520322-11-00 - 3. fázisTaking peopleAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Almería, Barcelona, Cabra, Castilleja De La Cuesta, Pozuelo de Alarcón, San Cugat del Vallés, Santa Cruz de Tenerife, Santander, Vic
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - 3. fázisTaking peopleA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Barcelona, Girona, L'Hospitalet de Llobregat (Barcelona), Monzón, Salamanca, Sevilla
- Életkor
- 18 év and over
- People
- 1060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - No phaseCsak meghívásosSMARTCLOTH. Design, Implementation and Study of the Effectiveness and Usability of a Digital Tablecloth for Self-management of Diet in Diabetic Patients.
- Where
- Córdoba
- Életkor
- 18 év to 70 év
- People
- 90
- Run by
- Maimónides Biomedical Research Institute of Córdoba
See details and how to joinNCT06623708 - 3. fázisFut, nem toborozA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- A Coruna, Barcelona, Castilleja De La Cuesta, Madrid, Pamplona, Santander, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- A Coruña, Badalona, Barcelona, Ferrol, Madrid, Málaga, Pozuelo de Alarcón, Sevilla
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisFut, nem toborozA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- A Coruna, Madrid, Pozuelo de Alarcón, Sevilla
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Barcelona, Málaga, Sevilla
- Életkor
- 10 év to 17 év
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Alzira, Barcelona, Castilleja De La Cuesta, Madrid, Málaga, Sevilla, Centro Médico Compostela
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- A Coruna, Almería, Barcelona, Castilleja De La Cuesta, Ferrol, Palma, Pozuelo de Alarcón, Santander, Sevilla
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisNot yet taking people in SpanyolországA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- A Coruña, Alzira (Valencia), Barcelona, Castilleja de La Cuesta, Sevilla, Ferrol (A Coruña), Lleida, Málaga, Oviedo, Segovia, Seville
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- A Coruña, Almería, Badalona, Barcelona, León, Madrid, Santander, Santiago de Compostela, Seville, Tarragona, Valencia
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleA Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
- Where
- A Coruña, Alzira, Barcelona, Castilleja De La Cuesta, Ferrol, Lleida, Málaga, Oviedo, Segovia, Sevilla
- Életkor
- 18 év and over
- People
- 420 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524616-11-00 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Barcelona, Centelles, Madrid, Santander, Sevilla, Vic
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00 - 3. fázisNot yet taking people in SpanyolországImpact of Semaglutide in Liver Transplant Candidates with Obesity (SOMAL Study): A Prospective Randomized Study.
- Where
- Murcia
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
See details and how to join2026-526953-32-00 - 3. fázisFut, nem toborozA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- A Coruña, Antequera, Barcelona, Centelles, Fuenlabrada, Girona, Madrid, Málaga, Manresa, Valladolid
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - No phaseTaking peopleInvolvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
- Where
- Valencia
- Életkor
- 18 év to 83 év
- People
- 120
- Run by
- Fundación para la Investigación del Hospital Clínico de Valencia
See details and how to joinNCT07828847 - 2. fázisFut, nem toborozA Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- A Estrada, Barcelona, Castilleja De La Cuesta, Girona, Santiago de Compostela
- Életkor
- 18 év to 75 év
- People
- 270 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00 - 3. fázisTaking peopleA trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
- Where
- A Coruna, Almería, Badalona, Barcelona, Castilleja De La Cuesta, León, Madrid, Santander, Santiago de Compostela, Sevilla, Tarragona, Valencia
- Életkor
- 18 év and over
- People
- 1010 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524688-19-00 - 3. fázisNot yet taking people in SpanyolországStudy of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
- Where
- Chiclana De La Frontera, Ferrol, Huelva, Madrid, Málaga, Salamanca, Santiago de Compostela, Sant Joan d'Alacant, Sevilla, Toledo, Valladolid
- Életkor
- 18 év and over
- People
- 760 worldwide
- Run by
- Tecnimede-Sociedade Tecnico-Medicinal S.A.
See details and how to join2025-524606-15-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Barcelona, Castilleja De La Cuesta, Ferrol, Lleida, Madrid, Majadahonda, Málaga, Santander, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 3. fázisNot yet taking people in SpanyolországAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- A Coruña, Barcelona, Móstoles, Sanlúcar de Barrameda, Santiago de Compostela, Segovia, Valencia
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335